Business context and reporting period
Entity discrepancy: Although the request identifies TERAWULF INC., the supplied Form 10-Q is for IKONICS Corporation (Nasdaq: IKNX), a maker of screen-printing, imaging, digital-texturing, and advanced-material products. This is an unaudited report for the quarter ended March 31, 2021; amounts below are U.S. dollars.
Financial results and liquidity
- Revenue: $3.073 million, down 12.1% from $3.497 million in Q1 2020. Gross profit was $996,000 (32.4% margin), versus $1.153 million (33.0%).
- Operating results: Operating loss was $322,000, improved from $811,000. Net loss was $322,000, or $0.16 per share, versus a $587,000 loss, or $0.30 per share. SG&A fell to $1.184 million from $1.781 million; Q1 2020 included $365,000 of one-time CEO-transition costs.
- Cash flow: Operating activities provided $771,000, compared with $427,000 used in Q1 2020. Investing activities used $7,000 and financing activities used $30,000. Cash increased to $4.428 million from $3.694 million at year-end.
- Balance sheet and debt: Current assets were $8.164 million and current liabilities $4.074 million at March 31. The company classified its $2.654 million loan balance as current after being told it would be recalled. It repaid the loan in full on April 1, 2021, using cash, paying about $2.7 million principal plus $6,100 interest. No line-of-credit borrowings were outstanding; the $2.05 million facility expired August 30, 2021.
- Other metrics: Total assets were $15.636 million and stockholders’ equity $11.562 million. Inventory rose to $1.962 million from $1.645 million.
Material changes versus the prior period
Segment sales declined at Chromaline (13.5%), Advanced Material Solutions (53.0%), and Digital Texturing (32.2%); IKONICS Imaging grew 12.0%, attributed to improving IKONART sales. AMS recorded a gross loss as lower volume weighed on its largely fixed cost base. The smaller net loss primarily reflected reduced operating expenses, while revenue and gross profit decreased. Operating cash flow improved, aided in part by working-capital movements, including lower receivables and higher accounts payable.
Outlook, risks, and unusual items
- Management expected COVID-19-related demand weakness to continue through most of 2021, adversely affecting sales, margins, and full-year results. The duration and magnitude of the impact were uncertain.
- Management cited cost reductions, including workforce reductions and curtailed discretionary spending, as mitigation. Planned 2021 capital expenditures were approximately $220,000, funded from cash and operating cash flow.
- The company said current resources, its credit line, and expected operating cash flow would be sufficient for operations, and separately stated it expected to have sufficient cash for more than twelve months. The credit line’s approaching August 2021 expiration and dependence on renewal are relevant to liquidity.
- A full valuation allowance was recorded against deferred tax assets because of cumulative losses. The Q1 2021 tax benefit was $20,000, versus $239,000 in Q1 2020, when a net operating loss carryback benefit affected the comparison.
- Foreign sales were 27% of revenue, versus 31% a year earlier. Management said foreign exchange effects were not material and reported no off-balance-sheet arrangements or legal proceedings.
Important facts for investors to verify
- Confirm the filing’s issuer: this supplied report is IKONICS Corporation’s, not TERAWULF INC.’s.
- Verify the April 1, 2021 repayment of the recalled $2.7 million loan and the post-repayment cash and debt position.
- Assess the credit line’s renewal or replacement after its August 30, 2021 expiration, given management’s stated dependence on renewal.
- Track COVID-19 impacts on segment demand and gross margins, especially AMS, and compare actual results with management’s 2021 expectations.
- Monitor cash generation, inventory levels, and the realizability of deferred tax assets given the cumulative-loss evidence cited in the filing.